University of Brasilia
unb.brTotal trials
65
Active
10
Phase 3
4
Total enrollment
5,714
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 6 of 6 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Liposomal Amphotericin B | — | — | — | — | 2 | ||
| Miltefosine 50mg | — | — | — | — | — | 1 | |
| Pentoxifylline 400mg | — | — | — | — | — | 1 | |
| Meglumine antimoniate | — | — | — | — | 4 | ||
| Miltefosine | — | — | — | — | — | 1 | |
| Pentoxifylline | — | — | — | — | — | 1 |
Next readouts
- 2024-06
- 2025-08
Top conditions
- Electrical Stimulation4
- Healthy4
- Aging3
- Radiodermatitis3
- Low Back Pain3
- Chronic Pain2
- Heart Failure2
- Educational Technology2
Frequently asked questions about University of Brasilia
- How many clinical trials does University of Brasilia have on ClinicalTrials.gov?
- University of Brasilia is listed as the lead sponsor on 65 clinical trials in ClinicalTrials.gov, 10 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University of Brasilia's trials are in Phase 3?
- 4 of University of Brasilia's trials are in Phase 3, spread across 6 active drug programs.
- What therapeutic areas does University of Brasilia focus on?
- University of Brasilia's most-studied conditions on ClinicalTrials.gov are Electrical Stimulation, Healthy, Aging, Radiodermatitis, Low Back Pain.
- When are University of Brasilia's next clinical trial readouts?
- University of Brasilia has 2 upcoming primary-completion readouts tracked here; the soonest is “Pilot Study: Oral Treatment of American Tegumentary Leishmaniasis (Cutaneous and Mucosal Forms) in the Elderly”, expected around 2024-06.